Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,646 | 5,286 | 2,981 | 6,602 | -1,509 |
| Depreciation Amortization | 247 | 64 | -90 | 51 | 19 |
| Income taxes - deferred | 429 | -11 | 1,475 | -3,048 | 0 |
| Accounts receivable | 2,051 | 78 | -1,845 | -1,251 | -459 |
| Other Working Capital | 787 | -916 | -3,664 | -4,809 | -1,295 |
| Other Operating Activity | -2,031 | 34 | 2,074 | 1,768 | 2,361 |
| Operating Cash Flow | $6,129 | $4,536 | $930 | $-688 | $-883 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,201 | -1,847 | -120 | 361 | -812 |
| PPE Investments | 1 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-5,200 | $-1,847 | $-120 | $361 | $-812 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,147 | 30 | 148 | 83 | 673 |
| Common Stock Repurchased | -830 | -675 | -1,035 | -740 | -458 |
| Other Financing Activity | 1,940 | 197 | 263 | 1,710 | 0 |
| Financing Cash Flow | $3,257 | $-448 | $-624 | $1,053 | $215 |
| Beginning Cash Position | 5,625 | 3,384 | 3,197 | 2,471 | 3,950 |
| End Cash Position | 9,811 | 5,625 | 3,384 | 3,197 | 2,471 |
| Net Cash Flow | $4,186 | $2,241 | $187 | $726 | $-1,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,129 | 4,536 | 930 | -688 | -883 |
| Free Cash Flow | 6,129 | 4,536 | 930 | -688 | -883 |